in ,

Russia COVID-19 inoculation drive lags as vaccine reluctance, supply issues persist


While at the Park House shopping mall in northern Moscow, Vladimir Makarov saw it was offering the coronavirus vaccine to customers, so he asked how long it would take.

“It turned out it’s simple here — 10 minutes,” he said of his experience last month.But Makarov, like many Muscovites, still decided to put off getting the Sputnik V shot.

For more coronavirus news, visit our dedicated page.

Russia boasted last year of being first in the world to authorize a coronavirus vaccine, but it now finds itself lagging in getting its population immunized. That has cast doubt on whether authorities will reach their ambitious goal of vaccinating more than 30 million of country’s 146 million people by mid-June and nearly 69 million by August.

The vaccine reluctance comes as shots are readily available in the capital to anyone 18 or older at more than 200 state and private clinics, shopping malls, food courts, hospitals — even a theater.

As of mid-April, over 1 million of Moscow’s 12.7 million residents, or about 8 percent, have received at least one shot, even though the campaign began in December.

That percentage is similar for Russia as a whole. Through April 27, only 12.1 million people have gotten at least one shot and only 7.7 million, or 5 percent, have been fully vaccinated. That puts Russia far behind the US, where 43 percent have gotten at least one shot, and the European Union with nearly 27 percent.

Data analyst Alexander Dragan, who tracks vaccinations across Russia, said last week the country was giving shots to 200,000-205,000 people a day. In order to hit the mid-June target, it needs to be nearly double that.

“We need to start vaccinating 370,000 people a day, like, beginning tomorrow,” Dragan told The Associated Press.

Russia’s lagging vaccination rates hinge on several factors, including supply. Russian drug makers have been slow to ramp up mass production, and there were shortages in March in many regions.

So far, only 28 million two-dose sets of all three vaccines available in Russia have been produced, with Sputnik V accounting for most of them, and only 17.4 million have been released into circulation after undergoing quality control.

Waiting lists for the shot remain long in places. In the Sverdlovsk region, the fifth most-populous in Russia, 178,000 people were on a wait list by mid-April, regional Deputy Health Minister Yekaterina Yutyaeva told AP.

On April 28, Kremlin spokesman Dmitry Peskov said there are enough vaccines available in Russia, adding that demand was the defining factor in the country’s vaccination rate.

Another factor in Russians’ reluctance over Sputnik V was the fact that it was rolled out even as large-scale testing to ensure its safety and efficacy was still ongoing. But a study published in February in the British medical journal The Lancet said the vaccine appeared safe and highly effective against COVID-19, according to a trial involving about 20,000 people in Russia.

A poll in February by Russia’s top independent pollster, the Levada Center, showed that only 30 percent of respondents were willing to get Sputnik V, one of three domestically produced vaccines available. The poll had a margin of error of 3.4 percentage points.

Dragan, the data analyst, says one possible explanation for the reluctance is the narrative from authorities that they have tamed the outbreak, even if that assessment might be premature.

With most virus restrictions lifted and government officials praising the Kremlin’s pandemic response, few have motivation to get the shot, he said, citing an attitude of, “If the outbreak is over, why would I get vaccinated?”

Vasily Vlassov, a public health expert at the Higher School of Economics in Moscow, echoed Dragan’s sentiment and also pointed to inconsistent signals from officials and media.

“Russians in 2020 were bombarded with contradictory messages — first about (the coronavirus) not being dangerous and being just a cold, then that it was a deadly infection,” he told AP. “Then they were banned from leaving their homes.”

Another narrative, he said, was that foreign vaccines were dangerous but Russian-produced ones were not. State TV reported adverse reactions linked to Western vaccines while celebrating Sputnik V’s international success.

A proper media campaign promoting vaccinations didn’t begin on state TV until late March, observers and news reports note. Videos on the Channel 1 national network featured celebrities and other public figures talking about their experience but didn’t show them getting injected. President Vladimir Putin said he received the shot about the same time, but not on camera.

Rumors about the alleged dangers of vaccines actually surged on social media in December, when Russia began administering the shots, and have continued steadily since then, said social anthropologist Alexandra Arkhipova.

The rumors combined with other factors — the pseudoscience on Russian TV, vaccine distribution problems and an uneven rollout of the promotional campaign — to hamper the immunization drive, Arkhipova told AP.

Read more:

Russia produces first batch of COVID-19 vaccine for animals: Regulator

Russia records more than 400,000 excess deaths during COVID-19 pandemic: Reuters

Russia says Brazil’s decision not to import Sputnik V vaccine politically motivated



Source | alarabiya

India second in ICC T20I rankings, drop to third in

India second in ICC T20I rankings, drop to third in ODIs after annual update | Cricket News

Financial Express - Business News, Stock Market News

Top-performing ETFs in US stock market